ATMP | Pharmaceuticals | Regulatory Rapporteur

Skip to main content
Skip to navigation

Advanced Therapy Medicinal Products

Near-term challenges of advanced therapy medicinal products: a maturing product class
2024-05-17T08:24:00+01:00
RegRapPod − May 2024
2024-05-08T16:30:00+01:00
Cell gene therapy: clinical trial application procedure of CAR-T therapy in the EU
2024-05-08T10:30:00+01:00
The first approval of a CRISPR-Cas9 gene editing medicinal product in the European Union: Casgevy
2024-05-08T10:30:00+01:00
Near-term challenges of advanced therapy medicinal products: a maturing product class
2024-05-08T10:00:00+01:00
May 2024 – Contents
2024-05-08T09:30:00+01:00

Dr Peter Marks on reflecting innovation through FDA regulation
2024-05-08T08:30:00+01:00
RegRapPod − February 2024
2024-02-20T16:51:00+00:00
RegRapPod − January 2024
2024-01-15T00:05:00+00:00
A weight of evidence approach for the non-clinical evaluation of complex biologicals
2024-01-05T00:05:00+00:00
Cell and gene therapy – navigating complexities in CMC development for optimisation of global regulatory strategies
2024-01-05T00:05:00+00:00
Innovating and harmonising access and requirements amid the global regulatory challenges of biologics
2024-01-05T00:05:00+00:00

More ATMP content